366
Views
2
CrossRef citations to date
0
Altmetric
Articles

Effectiveness of pregabalin treatment for trigger points in patients with comorbid myofascial pain syndrome and fibromyalgia syndrome: a randomized controlled trial

, , , , &
Pages 327-332 | Received 05 Aug 2021, Accepted 02 Sep 2021, Published online: 20 Sep 2021

References

  • Affaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E, Giamberardino MA. 2011. Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain. 15(1):61–69.
  • Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, Lapenna D, Giamberardino MA. 2009. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther. 31(4):705–720.
  • Alonso-Blanco C, Fernández-de-las-Peñas C, Morales-Cabezas M, Zarco-Moreno P, Ge HY, Florez-García M. 2011. Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. Clin J Pain. 27(5):405–413.
  • Bendtsen L, Fernández-de-la-Peñas C. 2011. The role of muscles in tension-type headache. Curr Pain Headache Rep. 15(6):451–458.
  • Borg-Stein J, Iaccarino MA. 2014. Myofascial pain syndrome treatments. Phys Med Rehabil Clin N Am. 25(2):357–374.
  • Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, et al. 2005. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 114(1–2):29–36.
  • Bouzia A, Tassoudis V, Karanikolas M, Vretzakis G, Petsiti A, Tsilimingas N, Arnaoutoglou E. 2017. Pregabalin effect on acute and chronic pain after cardiac surgery. Anesthesiol Res Pract. 2017:2753962.
  • Buvanendran A, Kroin JS, Della Valle CJ, Kari M, Moric M, Tuman KJ. 2010. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anesth Analg. 110(1):199–207.
  • Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W. 2007. Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth. 98(2):246–254.
  • Crofford LJ, Mease PJ, Simpson SL, Young JP, Jr, Martin SA, Haig GM, Sharma U. 2008. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 136(3):419–431.
  • Desai MJ, Saini V, Saini S. 2013. Myofascial pain syndrome: a treatment review. Pain Ther. 2(1):21–36.
  • Dooley DJ, Taylor CP, Donevan S, Feltner D. 2007. Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci. 28(2):75–82.
  • Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su T-Z, Bramwell S, Corradini L, England S, Winks J, et al. 2006. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin . Proc Natl Acad Sci USA. 103(46):17537–17542. USA.
  • Gerwin RD. 2013. Diagnosing fibromyalgia and myofascial pain syndrome: a guide. J Fam Pract. 12 (Suppl: 62):19–25.
  • Hsieh L-F, Hong C-Z, Chern S-H, Chen C-C. 2010. Efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of the upper trapezius. J Pain Symptom Manag. 39(1):116–125.
  • Ketenci A, Basat H, Esmaeilzadeh S. 2009. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study. Agri. 21(3):95–103.
  • Kim DY, Kim JM. 2018. Safety and efficacy of prabotulinumtoxinA (Nabota®) injection for cervical and shoulder girdle myofascial pain syndrome: a pilot study. Toxins. 10(9):355.
  • Lubis AMT, Rawung RBV, Tantri AR. 2018. Preemptive analgesia in total knee arthroplasty: comparing the effects of single dose combining celecoxib with pregabalin and repetition dose combining celecoxib with pregabalin: double-blind controlled clinical trial. Pain Res Treat. 2018:3807217.
  • Malanga G, Gwynn M, Smith R, Miller D. 2002. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician. 5:422–432.
  • Nicol AL, Wu II, Ferrante FM. 2014. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design. Anesth Analg. 118(6):1326–1335.
  • Palacios-Ceña M, Wang K, Castaldo M, Guillem-Mesado A, Ordás-Bandera C, Arendt-Nielsen L, Fernández-de-las-Peñas C. 2018. Trigger points are associated with widespread pressure pain sensitivity in people with tension-type headache. Cephalalgia. 38(2):237–245.
  • Pinar R. 2005. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res. 14(1):259–264.
  • Price DD, McGrath PA, Rafii A, Buckingham B. 1983. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 17(1):45–56.
  • Sattari H, Hashemian M, Lashkarizadeh MR, Jalalifard H. 2018. Preoperative oral pregabalin reduces acute pain after thoracotomy. Open Access Maced J Med Sci. 6(9):1606–1610.
  • Simons DG, Travell JG, Simons SL. 1999. Myofascial pain and dysfunction: the trigger point manual. 2nd ed. Baltimore (MD): Lippincott Williams & Wilkins.
  • Taylor CP, Angelotti T, Fauman E. 2007. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery . Epilepsy Res. 73(2):137–150.
  • Unal Cevik I, Sarioglu-Ay S, Evcik DA. 2010. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. J Pain. 11(11):1129–1135.
  • Ware JE, Sherbourne CD. 1992. The Medical Outcomes Study (MOS) 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 30(6):473–483.
  • Yunus MB. 2008. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 37(6):339–352.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.